Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pseudouridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel bioenzymatic route for high-purity pseudouridine. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing.
Patent CN119776462A reveals one-pot enzymatic synthesis for pseudouridine. High purity and yield offer significant supply chain and cost advantages for mRNA manufacturers.
Novel chemo-enzymatic route for pseudouridine offers high purity and scalable production for mRNA vaccine manufacturers seeking reliable supply.
Patent CN114196715A details a novel chemo-enzymatic method for pseudouridine using engineered glycosidase mutants, offering high conversion and simplified purification for mRNA vaccine supply chains.
Patent CN119431334A details a high-yield synthesis of 2'OMe pseudouridine. This method offers significant cost reduction and supply chain reliability for mRNA manufacturing.
Novel 3-step chemical synthesis of pseudouridine using 2,3,5-tribenzyloxy-D-ribono-1,4-lactone. High yield, scalable process for mRNA therapeutics and reliable supply.
New synthesis method for pseudouridine intermediate reduces costs by 30% with 82% yield. Simplified process eliminates expensive reagents and complex quenching steps for stable supply chain.